Financial Toxicity and Quality of Life in Patients Undergoing Stem-Cell Transplant Evaluation: A Single-Center Analysis
JCO Oncology Practice · 2024-03 · 20 (3) · 351-360
DOI: 10.1200/op.23.00243 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Oncology Practice, 2024-03. Verfasst von S M Qasim Hussaini und 18 weiteren Autor:innen. Beteiligte Einrichtung: O'Neal Comprehensive Cancer, University of Alabama at Birmingham, Birmingham, AL. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Leukemia. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
PURPOSE We investigated the prevalence of financial toxicity in a population undergoing hematopoietic cell transplantation (HCT) evaluation and measured its impact on post-transplant clinical and health-related quality-of-life outcomes. MATERIALS AND METHODS This was a prospective study in patients undergoing evaluation for allogeneic HCT between January 1, 2018, and September 23, 2020, at a large academic medical center. Financial health was measured via a baseline survey and the comprehensive score for financial toxicity-functional assessment of chronic illness therapy (COST-FACIT) survey. The cohort was divided into three groups: none (grade 0), mild (grade 1), and moderate-high financial toxicity (grades 2-3). Health-related quality of life outcomes were measured at multiple time points. Multivariate logistic regression analysis evaluated factors associated with financial toxicity. Kaplan-Meier curves and log-rank tests was used to evaluate overall survival (OS) and nonrelapse survival. RESULTS Of 245 patients evaluated for transplant, 176 (71.8%) completed both questionnaires (median age was 57 years, 63.1% were male, 72.2% were White, and 39.2% had myelodysplastic syndrome, 38.1% leukemia, and 13.6% lymphoma). At initial evaluation, 83 (47.2%) patients reported no financial toxicity, 51 (29.0%) with mild, and 42 (23.9%) with moderate-high financial toxicity. Patients with financial toxicity reported significant cost-cutting behaviors, including reduced spending on food or clothing, using their savings, or not filling a prescription because of costs ( P < .0001). Quality of life was lower in patients with moderate-high financial toxicity at 6 months ( P = .0007) and 1 year ( P = .0075) after transplant. Older age (>62; odds ratio [OR], 0.33 [95% CI, 0.13 to 0.79]; P = .04) and income ≥$60,000 in US dollars (USD) (OR, 0.17 [95% CI, 0.08 to 0.38]; P < .0001) were associated with lower odds of financial toxicity. No association was noted between financial toxicity and selection for transplant, OS, or nonrelapse mortality. CONCLUSION Financial toxicity was highly correlated with patient-reported changes in compensatory behavior, with notable impact on patient quality of life after transplant.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- O'Neal Comprehensive Cancer, University of Alabama at Birmingham, Birmingham, AL.
- Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, MD.
- Department of Medicine, Duke University School of Medicine, Durham, NC.
- Duke Cancer Institute Biostatistics Shared Resource, Durham, NC.
- Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, NC.
ORCID-Profile: S M Qasim Hussaini, Lauren Bohannon, Ernaya Johnson, Taewoong Choi, Mitchell E Horwitz, S Yousuf Zafar, Anthony D Sung
Förderung
- NIA NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Hussaini, S. M. Q., Ren, Y., Racioppi, A., Lew, M. V., Bohannon, L., Johnson, E., Li, Y., Thompson, J. C., Henshall, B., Darby, M., Choi, T., Lopez, R. D., Sarantopoulos, S., Gasparetto, C., Long, G. D., Horwitz, M. E., Chao, N. J., Zafar, S. Y., & Sung, A. D. (2024). Financial Toxicity and Quality of Life in Patients Undergoing Stem-Cell Transplant Evaluation: A Single-Center Analysis. JCO Oncology Practice, 20(3), 351-360. https://doi.org/10.1200/op.23.00243
Vancouver
Hussaini SMQ, Ren Y, Racioppi A, Lew MV, Bohannon L, Johnson E, et al. Financial Toxicity and Quality of Life in Patients Undergoing Stem-Cell Transplant Evaluation: A Single-Center Analysis. JCO Oncology Practice. 2024;20(3):351-360. doi:10.1200/op.23.00243
BibTeX
@article{Hussaini2024,
author = {Hussaini, S M Qasim and Ren, Yi and Racioppi, Alessandro and Lew, Meagan V and Bohannon, Lauren and Johnson, Ernaya and Li, Yan and Thompson, Jillian C and Henshall, Bethany and Darby, Maurisa and Choi, Taewoong and Lopez, Richard D and Sarantopoulos, Stefanie and Gasparetto, Cristina and Long, Gwynn D and Horwitz, Mitchell E and Chao, Nelson J and Zafar, S Yousuf and Sung, Anthony D},
title = {Financial Toxicity and Quality of Life in Patients Undergoing Stem-Cell Transplant Evaluation: A Single-Center Analysis},
journal = {JCO Oncology Practice},
year = {2024},
volume = {20},
number = {3},
pages = {351--360},
doi = {10.1200/op.23.00243}
}
EUVIMED